These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1647670)

  • 41. Recognition of neuropeptides FMRFamide and LPLRFamide by chicken cerebellum avian pancreatic polypeptide binding sites.
    Ganeshan K; Perlman MO; Perlman JM; Adamo ML; Hazelwood RL; Dyckes DF
    Proc Soc Exp Biol Med; 1987 Sep; 185(4):409-12. PubMed ID: 3615408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes.
    Igwe OJ; Kim DC; Seybold VS; Larson AA
    J Neurosci; 1990 Nov; 10(11):3653-63. PubMed ID: 1700082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptors on phaeochromocytoma cells for two members of the PP-fold family--NPY and PP.
    Schwartz TW; Sheikh SP; O'Hare MM
    FEBS Lett; 1987 Dec; 225(1-2):209-14. PubMed ID: 2826239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Br J Pharmacol; 2003 Aug; 139(7):1360-8. PubMed ID: 12890716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex.
    Westlind-Danielsson A; Undén A; Abens J; Andell S; Bartfai T
    Neurosci Lett; 1987 Feb; 74(2):237-42. PubMed ID: 3033554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.
    Laburthe M; Chenut B; Rouyer-Fessard C; Tatemoto K; Couvineau A; Servin A; Amiranoff B
    Endocrinology; 1986 May; 118(5):1910-7. PubMed ID: 3009142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological characterization of somatostatin receptors in the rat cerebellum during development.
    Gonzalez BJ; Leroux P; Bodenant C; Braquet P; Vaudry H
    J Neurochem; 1990 Sep; 55(3):729-37. PubMed ID: 1974603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression cloning of a human brain neuropeptide Y Y2 receptor.
    Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA
    Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide Y receptor in the rat brain.
    Undén A; Tatemoto K; Mutt V; Bartfai T
    Eur J Biochem; 1984 Dec; 145(3):525-30. PubMed ID: 6096141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
    Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
    Endocrinology; 1992 Oct; 131(4):1970-6. PubMed ID: 1327725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cysteamine selectively enhances neuropeptide Y2 receptor binding activity.
    Li W; Hexum TD
    Biochem Biophys Res Commun; 1992 Apr; 184(1):380-6. PubMed ID: 1314592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of neuropeptide Y (NPY) receptors in human hippocampus.
    Li W; Hexum TD
    Brain Res; 1991 Jul; 553(1):167-70. PubMed ID: 1657277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2-[125I]iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution.
    Duncan MJ; Takahashi JS; Dubocovich ML
    Endocrinology; 1988 May; 122(5):1825-33. PubMed ID: 2834175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High affinity angiotensin II receptors in myocardial sarcolemmal membranes. Characterization of receptors and covalent linkage of 125I-angiotensin II to a membrane component of 116,000 daltons.
    Rogers TB
    J Biol Chem; 1984 Jul; 259(13):8106-14. PubMed ID: 6330100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the binding of [3H]proprionyl-neuropeptide Y to rat and human frontal cortical membranes.
    Widdowson PS; Halaris AE
    J Neurochem; 1990 Sep; 55(3):956-62. PubMed ID: 2384761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iodinated-NPY binding sites: autoradiographic study in the rat brain.
    Giardino L; Calzà L; Zanni M; Parchi P; Battistini N; Marrama P
    Neuropeptides; 1989 Jan; 13(1):23-8. PubMed ID: 2537936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.